Haleon (HLN) Non-cash Items (2021 - 2022)

Haleon (HLN) recorded quarterly Non-cash Items of $1.0 billion in Q3 2022, down 2.22% on a QoQ basis from $1.0 billion in Q2 2022.

Haleon (HLN) Non-cash Items (2021 - 2022) Analysis & Trends

Haleon has disclosed Non-cash Items across 2 years of filings, most recently posting $1.0 billion for Q3 2022.

Quarterly Non-cash Items changed N/A year-over-year to $1.0 billion in Q3 2022, while the trailing twelve-month figure through Sep 2022 was $1.0 billion (changed N/A YoY) and the FY2021 annual result came in at $520.3 million, changed N/A from the prior year.
Non-cash Items declined to $1.0 billion in Q3 2022, from $1.0 billion in the prior quarter.
Over five years, Non-cash Items peaked at $1.0 billion in Q2 2022 and troughed at $520.3 million in Q4 2021.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Teva Pharmaceutical Industries	39.72 Bn	35.98 Bn	1.97 Bn
2	Zoetis	34.61 Bn	32.67 Bn	1.62 Bn
3	United Therapeutics	24.07 Bn	21.91 Bn	648.10 Mn
4	Aurora Cannabis	16.98 Bn	16.91 Bn	33.43 Mn
5	Neurocrine Biosciences	16.64 Bn	15.32 Bn	800.70 Mn
6	Elanco Animal Health	12.19 Bn	11.76 Bn	785.00 Mn
7	Alkermes	7.37 Bn	6.86 Bn	-116.06 Mn
8	Hims & Hers Health	6.62 Bn	5.87 Bn	396.79 Mn
9	Lantheus Holdings	6.47 Bn	5.97 Bn	230.92 Mn
10	Haleon	1.09 Bn	-773.69 Mn	-

Download Data